Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B [clinicaltrials:NCT00007332]
Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B [clinicaltrials:NCT00007332]
Bio2RDF identifier
NCT00007332
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00007332
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... seem to be safe to
use.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Immune Response Stu ...... n Combination With AIDSVAX B/B
completion date [clinicaltrials_vocabulary:completion-date]
2003-04-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
There is no cure for HI ...... ring the course of the trial.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-12-16T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
AIDS Vaccines
CD8-Positive T-Lymphocytes
Drug Therapy, Combination
HIV Envelope Protein gp120
HIV Preventive Vaccine
HIV Seronegativity
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-05-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct alias [clinicaltrials_vocabulary:nct-alias]
NCT00006147
nct id [clinicaltrials_vocabulary:nct-id]
NCT00007332
official title [clinicaltrials_vocabulary:official-title]
A Phase II Clinical Trial to E ...... ALVAC vCP1452 and AIDSVAX B/B
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-05-01T00:00:00Z
identifier
clinicaltrials:NCT00007332
title
Safety and Immune Response Stu ...... n Combination With AIDSVAX B/B
@en
type
label
Safety and Immune Response Stu ...... B [clinicaltrials:NCT00007332]
@en